Renal Flashcards
Pathological type of RCC
Rakib sir
Clear cell 75%
Non clear cell:
- papillary
- chromophobe
-oncocytic
- sarcomatoid( bad prognosis/ aggressive)
Other: ewings
Renal cell tumor
clear cell RCC (80-90%)-
papillary RCC (10-15%)-
Chromophobe RCC (4-5%)-
ca of the collecting ducts of bellini <1%-
Renal medullary ca -very aggressive-
oncocytoma
other -
tubulocycarcinoma-
papillary adenoma
predominant histologica type: adenocarcinoma
other pathological types of RCC
B. Metanephric tumors-
metanephric adenoma-
metanephric
C. Mesenchymal tumors-
leiomyosarcoma-
angiosarcoma-
rhabdomyosarcoma-
osteosarcoma -
synovial sarcoma-
hemangioma
D. Mixed epithelial and stromal tumor
E. Germ cell tumor
F. Metastatic tumor
Secondary renal tumors example
usually bilaterallung 20%,
breast 12%
stomach 11%ovary-
opposite kidney
NHL
risk factors of RCC
Environmental
cadmium exposure-
asbestos,
petroleum-
analgesic-
phenacetin
occupational
leather worker-
shoe -
asbestos worker-
oil refinery
hormonal
diethystibestrol-
cytoxic CT in childhood
Renal:-
dialysis-
RCC-Renal transplant
other
obesity,
smoking,
HTN,
tuberous sclerosis
genetic/familiar cause of RCC
Von hippel lindau disease
protein polybromo gene 1
papillary renal cell carcinoma
paraneoplastic syndrome associated with renal cell carcinoma
hypercalcemia
polycythemia
polyneuropathy
amyloidosis
hypercalcemia are common PNS in
sq cell carcinoma of lung
breast carcinoma
RCC
adult T cell leukemia
ovarian carcinoma
common site of distant metastasis in RCC
bone, liver, lung , brain, soft tissue
lung 75% ??
MSKCC prognostic factor for renal cell cancer
Interval from diagnosis to treatment of less than 1 year•
Karnofsky performance status less than 80%•
Serum LDH greater than 1.5 times the upper limit of normal (ULN) •
Corrected serum calcium greater than the ULN•
Serum hemoglobin less than the lower limit of normal (LLN)
Common drug used
Preferred regimen for clear cell histology: if favorable histology
- Axitinib+ pembrolizumab
- Cabozantinib + nivolumab
- Lenvatinib + pembrolizumab
Other:
- axitinib + avelumab
- Cabozantinib
- Ipilimumab + nivolumab
- Pazopanib
- Sunitinib
Prognosis depends on(rakib sir)
Albumin
ESR
Hb%
Alk phosphatase
Performance status
Calcium